Mariner’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-28,374
Closed -$113K 774
2019
Q2
$113K Hold
28,374
﹤0.01% 1076
2019
Q1
$207K Hold
28,374
﹤0.01% 958
2018
Q4
$260K Hold
28,374
﹤0.01% 702
2018
Q3
$352K Hold
28,374
0.01% 621
2018
Q2
$433K Hold
28,374
0.01% 570
2018
Q1
$563K Buy
28,374
+50
+0.2% +$863 0.02% 414
2017
Q4
$530K Hold
28,324
0.02% 382
2017
Q3
$609K Hold
28,324
0.03% 313
2017
Q2
$273K Hold
28,324
0.01% 423
2017
Q1
$169K Sell
28,324
-3,750
-12% -$18K 0.01% 557
2016
Q4
$127K Buy
32,074
+7,450
+30% +$54.6K 0.01% 541
2016
Q3
$259K Buy
+24,624
New +$354K 0.01% 503

Other funds holding DVAX

Mariner's DVAX Position: Q3 2019 in Review

Mariner sold out of Dynavax Technologies (DVAX) in Q3 2019, closing a stake of 28,374 shares — an estimated $113K sold.

Mariner first reported a position in DVAX in Q3 2016 and held it in 12 quarters. The position peaked at $609K in Q3 2017. 117 funds tracked by Wall St. Rank hold DVAX as of Q3 2019.

  • Mariner reported no remaining Dynavax Technologies position as of Q3 2019 after selling out during the quarter.
  • Mariner sold 28,374 Dynavax Technologies shares in Q3 2019, an estimated $113K.
  • Mariner first reported a position in Dynavax Technologies in Q3 2016 and held it in 12 quarters.
  • Mariner's Dynavax Technologies position peaked at $609K in Q3 2017.
  • 117 funds tracked by Wall St. Rank held Dynavax Technologies as of Q3 2019.

Based on Mariner's 13F filing for Q3 2019, filed 13 Nov 2019.